Unmasking the specificity paradox: why pharmacological class, not the strategy, defines success in intracoronary thrombolysis for stemi (role of fibrin specificity following the STRIVE trial)

28 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Beyond myocardial ischaemia: different aspects of pharmacotherapy and revascularisation Revascularisation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology